Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2003
11/27/2003WO2003097866A1 Biosensor
11/27/2003WO2003097864A1 Method and reagent system having a non-regenerative enzyme-coenzyme complex
11/27/2003WO2003097863A1 Method and reagent system having an inactivated enzyme
11/27/2003WO2003097862A1 Method of searching substane having antidiabetic activity
11/27/2003WO2003097861A1 Method and device for detecting toxic material in water using microbial fuel cell
11/27/2003WO2003097860A1 Analyte measurement
11/27/2003WO2003097859A2 Method for producing polymer layers
11/27/2003WO2003097857A2 Method for the detection of aquaretic compounds
11/27/2003WO2003097856A2 Plating media
11/27/2003WO2003097854A2 Novel biomarkers of tyrosine kinase inhibitor exposure and activity in mammals
11/27/2003WO2003097852A2 Assay for identifying inhibitors of fc gamma riii signaling
11/27/2003WO2003097850A1 Simulating microarrays using a parameterized model
11/27/2003WO2003097835A2 Pharmaceutical compositions for the treatment of cancer
11/27/2003WO2003097811A2 Cellular gene targets for controlling cell growth
11/27/2003WO2003097803A2 Cancer-linked gene as target for chemotherapy
11/27/2003WO2003097795A2 Constitutively translocating cell line
11/27/2003WO2003097793A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/27/2003WO2003097792A2 Polypeptide immobilization
11/27/2003WO2003097789A2 Farnesyl diphosphate synthase from pseudomonas aeruginosa
11/27/2003WO2003097786A1 Conductive microplate
11/27/2003WO2003097699A1 Immobilization of glycoproteins
11/27/2003WO2003097691A1 Sodium channel regulators and modulators
11/27/2003WO2003097686A1 Novel protein, its dna and use thereof
11/27/2003WO2003097682A1 Methods for identifying and developing compounds that interact with voltage-gated potassium channels of the kv4 family
11/27/2003WO2003097667A1 Methods for measuring kinase activity and phosphatase activity
11/27/2003WO2003097666A2 Use of gastrin releasing peptide (grp) and its receptor in cancer screening
11/27/2003WO2003097665A2 Mid 241 receptor, a novel g-protein coupled receptor
11/27/2003WO2003097097A1 Method of treating and/or preventing acute leukemia using medicinal composition for therapeutic use containing vla4 antagonist, and method of diagnosing prognosis of acute leukemia using vla4 as indication
11/27/2003WO2003097088A2 Methods to detect, isolate, target and manipulate hiv-infected t cells
11/27/2003WO2003097049A1 Anti-estrogen receptor agents for chemotherapy and prevention
11/27/2003WO2003096974A2 ORIENTIA TSUTSUGAMUSHI TRUNCATED RECOMBINANT OUTER MENBRANE PROTEIN (r47) AND (r56) VACCINES DIAGNOSTICS AND THERAPEUTICS FOR SCRUB TYPHUS AND HIV INFECTION
11/27/2003WO2003096876A2 Continuously operational diagnostic device
11/27/2003WO2003083096A3 Cancer associated protein kinases and their uses
11/27/2003WO2003082189A3 Method for producing pseudo islets
11/27/2003WO2003080793A3 Treating solution containing aluminium ion for staining protein and staining method using the same
11/27/2003WO2003080570A3 Recombinant expression vectors for functional nav1.9 sodium channels
11/27/2003WO2003079748A3 Potentiation of cancer therapies by znf217 inhibition
11/27/2003WO2003078693A3 System and method for determining fouling tendency by refinery feed stocks
11/27/2003WO2003078589A3 Method of identifying genes controlling diferentiation
11/27/2003WO2003075307B1 Methods, devices, and systems using acoustic ejection for depositing fluid droplets on a sample surface for analysis
11/27/2003WO2003074725A3 MBCATs AS MODIFIERS OF THE BETA-CATENIN PATHWAY AND METHODS OF USE
11/27/2003WO2003073980A3 Recombinant protein c variants
11/27/2003WO2003070157A3 Vitamin d upregulated protein 1 (vdup-1) methods and uses thereof
11/27/2003WO2003068940A3 Complexes and methods of using same
11/27/2003WO2003067021A3 Multi-parameter monitoring tool assembly
11/27/2003WO2003066807A9 Method of inhibiting pathogenicity of infectious agents
11/27/2003WO2003064604A3 Translation profiling
11/27/2003WO2003061590A3 Peptide constructs for treating disease
11/27/2003WO2003061583A9 Digenic mutations associated with severe insulin resistance and type 2 diabetes and their use in the diagnosis and treatment of diabetes
11/27/2003WO2003060492A8 Refractometer
11/27/2003WO2003060472A3 An immunochromatographic assay for emp
11/27/2003WO2003056329A3 Use of a signal transduction complex in drug discovery processes
11/27/2003WO2003055505A3 Sk-3 potassium channels and the treatment of sexual dysfunctions and/or vascular disorders
11/27/2003WO2003052415A3 Test system for identifying or testing active substances, which affect the growth and/or the survival of nerve cells
11/27/2003WO2003051383A3 Use of hmgb proteins and nucleic acids that code therefor
11/27/2003WO2003050291A3 Sensor for the use in testing biological chemical or environmental samples
11/27/2003WO2003048789A3 Electrodynamic sensors and applications thereof
11/27/2003WO2003048771A3 Device for analysing analyte compounds and use hereof
11/27/2003WO2003048723A3 Label-free detection of nucleic acids via surface plasmon resonance
11/27/2003WO2003048300A3 Methods of identifying cellular target molecules
11/27/2003WO2003046212A3 Method for identifying target epitopes of the t cell mediated immune response and for assaying epitope-specific t cells
11/27/2003WO2003043986A3 Polypeptides of moraxella (branhamella) catarrhalis
11/27/2003WO2003043978A3 Method for selective conjugation of analytes to enzymes without unwanted enzyme-enzyme cross-linking
11/27/2003WO2003042700A3 Breast cancer associated polypeptide
11/27/2003WO2003040401A3 General screening method for ligand-protein interactions
11/27/2003WO2003040299A3 Method of selecting hla-dp4 ligands and the applications thereof
11/27/2003WO2003038685A3 Method for monitoring a public water treatment system
11/27/2003WO2003038397A3 Assay
11/27/2003WO2003034803A8 Methods for determining toxicity reversing agents
11/27/2003WO2003034026A3 Microwell biochip
11/27/2003WO2003031976A3 Calibrating microarrays
11/27/2003WO2003031578A3 Mammalian c-type lectins
11/27/2003WO2003031573A3 Toll-like receptor 3 signaling agonists and antagonists
11/27/2003WO2003029463A3 Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
11/27/2003WO2003027669A3 Method for producing a normalized gene library from nucleic acid extracts of soil samples and the use thereof
11/27/2003WO2003027262A3 Biological discovery using gene regulatory networks generated from multiple-disruption expression libraries
11/27/2003WO2003025584A3 Direct serum lipids assays for evaluation of disease states
11/27/2003WO2003023406A3 Diagnostic method for transmissible spongiform encephalopathies
11/27/2003WO2003023366A3 Method and system for classifying a scenario
11/27/2003WO2003023354A3 Optical bio-disc systems for nuclear morphology based identification
11/27/2003WO2003021274A3 Method for separating macromolecules having been chemically modified in a reversible manner
11/27/2003WO2003020977A3 Nucleotide repeats assay
11/27/2003WO2003020759A3 A caspase- 8 binding protein, its preparation and use
11/27/2003WO2003020204A3 Detection of bovine viral diarrhea virus in tissue samples
11/27/2003WO2003019165A3 Method and apparatus for calibrating electrochemical sensors
11/27/2003WO2003017127A3 Method for modelling biochemical pathways
11/27/2003WO2003016903A8 Device and method for determining an analyte
11/27/2003WO2003014144A3 Molecule
11/27/2003WO2003013590A8 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer
11/27/2003WO2003012064A3 Nucleic acids and encoded polypeptides associated with bipolar disorder
11/27/2003WO2003010544A8 Method for the diagnosis of kidney damage in the early stages
11/27/2003WO2003009100A3 Methods, apparatuses, and computer programs for verifying the integrity of a probe
11/27/2003WO2003006995A3 Method for identifying substances which modulate interleukin 4 (il-4) signaling
11/27/2003WO2003006611A3 GPCs AS MODIFIERS OF THE IRRTK AND p21 PATHWAYS AND METHODS OF USE
11/27/2003WO2003004990A3 Quantitative in vitro bone induction assay
11/27/2003WO2003003810A3 Methods for detection and quantification of analytes in complex mixtures
11/27/2003WO2003002979A3 Multiplex decoding of array sensors with microspheres
11/27/2003WO2002103008A3 Templated molecules and methods for using such molecules
11/27/2003WO2002099059A3 U5-200KDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
11/27/2003WO2002097075B1 Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties
1 ... 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 2464 2465 2466 2467 2468 2469 2470 2471 2472 2473 2474 ... 3937